FUSN - Fusion Pharmaceuticals  - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $21.76. This is a potential upside of $0.21 (0.97%) from yesterday's end of day stock price of $21.55.

Fusion Pharmaceuticals 's activity chart (see below) currently has 32 price targets and 26 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 58.33% with an average time for these price targets to be met of 253 days.

Most recent stock forecast was given by YUAN ZHI from B. RILEY on 19-Mar-2024. First documented stock forecast 20-Jul-2020.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

$13

$-8.55 (-39.68%)

$13

1 years 6 months 26 days ago
(19-Mar-2024)

3/4 (75%)

$-8.09 (-38.36%)

287

Hold

$16

$-5.55 (-25.75%)

$16

1 years 6 months 26 days ago
(19-Mar-2024)

1/2 (50%)

$-5.09 (-24.13%)

15

Hold

$11

$-10.55 (-48.96%)

$10

1 years 6 months 27 days ago
(18-Mar-2024)

1/2 (50%)

$-10.18 (-48.06%)

496

Buy

$13

$-8.55 (-39.68%)

$13

1 years 8 months 20 days ago
(25-Jan-2024)

2/3 (66.67%)

$2.11 (19.38%)

131

Buy

$16

$-5.55 (-25.75%)

$15

1 years 9 months 11 days ago
(04-Jan-2024)

4/4 (100%)

$7.65 (91.62%)

143

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is FUSN (Fusion Pharmaceuticals ) average time for price targets to be met?

On average it took 253 days on average for the stock forecasts to be realized with a an average price target met ratio 58.33

Which analyst has the current highest performing score on FUSN (Fusion Pharmaceuticals ) with a proven track record?

MATTHEW HARRISON

Which analyst has the current lower performing score on FUSN (Fusion Pharmaceuticals ) with a proven track record?

GREGORY RENZA

Which analyst has the most public recommendations on FUSN (Fusion Pharmaceuticals )?

Matthew Harrison works at MORGAN STANLEY and has 7 price targets and 8 ratings on FUSN

Which analyst is the currently most bullish on FUSN (Fusion Pharmaceuticals )?

John Walsh with highest potential upside - $0

Which analyst is the currently most reserved on FUSN (Fusion Pharmaceuticals )?

Matthew Harrison with lowest potential downside - -$11.55

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?